Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired gluose tolerance

Diabetologia

Volumn 39, Issue 9, 1996, Pages 1099-1107

  Larsson, H ^a   Ahren B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Glucagon secretion; Impaired glucose tolerance; Insulin secretion; Islet function; Non insulin dependent diabetes mellitus; Pathogenesis

Indexed keywords

ARGININE;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PANCREAS ISLET; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0029816099     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00400660     Document Type: Article

References (44)

1. Porte Jr D (1992) B cells in type 2 diabetes mellitus. Diabetes 40: 166-180
2. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368
3. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929
4. Lillioja S, Mott DM, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217-1225
5. Lundgren H, Bengtsson C, Blohmé G, Lapidus L, Waldenström J (1990) Fasting scrum insulin concentration and early insulin response as risk determinants for developing diabetes. Diabet Med 7: 407-413
6. Haffner SM, Stern P, Watanabe RM, Bergman RN (1992) Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. Eur J Clin Invest 22: 147-153
7. O'Rahilly SP, Rudenski AS, Burnett MA, Nugent Z, Hosker JP, Darling P (1986) Beta-cell dysfunction, rather than insulin insensitivily, is the primary defect in familial type 2 diabetes. Lancet 2: 360-364
8. Mitrakou A, Kelley D, Mokan M et al. (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326: 22-29
9. Kanatsuka A, Hideichi M, Sakurada M et al. (1988) First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate. Metabolism 37: 878-884
10. Sartor G, Scherstén B, Carlström S, Melander A, Norden Å, Persson G (1980) Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 29: 41-49
11. Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22: 73-78
12. Kadowaki T, Miyake Y, Hagura R et al. (1984) Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26: 44-19
13. Sicree RA, Zimmet PZ, King HOM, Coventry JS (1987) Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36: 179-186
14. Larsson H, Berglund G, Ahrén B (1995) Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. J Clin Endocrinol Metab 80: 1778-1782
15. Cerasi E, Luft R (1967) The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 55: 278-304
16. Cerasi E, Efendic S, Luft R (1973) Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 2: 794-797
17. Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-1992
18. O'Meara NM, Sturis J, van Cauter E, Polonsky KS (1993) Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellilus. J Clin Invest 92: 262-271
19. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96: 520-527
20. Swinburn BA, Gianchandani R, Saad MF, Lillioja S (1995) In vivo β-cell function at the transition to early non-insulin-dependent diabetes mellitus. Metabolism 44: 757-764
21. Alvarsson M, Wajngot A, Efendic S, Grill V (1995) Relationship between insulin responses to D-glucose and to L-arginine in women with a history of gestational diabetes. Acta Diabetol 32: 86-91
22. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte Jr D (1984) Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am J Physiol 247:E592-E596
23. Kahn SE, Beard JC, Schwartz MW et al. (1989) Increased B-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38: 562-568
24. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467
25. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
26. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte Jr D (1984) Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 74: 1318-1328
27. Larsson H, Ahrén B, Lindgärde F, Berglund G (1995) Fasting blood glucose in determining prevalence of diabetes in a large, homogenous population of Caucasian middle-aged women. J Intern Med 237: 537-541
28. World Health Organisation (1985) Diabetes mellitus: report of a WHO study group. World Health Organisation (Technical Report Series no 727), Geneva
29. Cerasi E (1975) Potentiation of insulin release by glucose in man. Acta Endocrinol 79: 511-534
30. Grill V (1981) Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol 240:E24-31
31. Halter JB, Graf RJ, Porte Jr D (1979) Potentiation of insulin secretory response by plasma glucose levels in man: Evidence that hyperglycaemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48: 946-954
32. Norusis MJ (1992) SPSS for Windows. Base system user's guide. Release 5.0. SPSS Inc., Chicago
33. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S (1993) Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes, J Clin Endocrinol Metab 76: 275-278
34. Lillioja S, Nyomba BL, Saad MF et al. (1991) Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 73: 866-876
35. Pollare T, Lithell H, Berne C (1990) Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39: 167-174
36. Campbell PJ, Gerich JE (1990) Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J Clin Endocrinol Metab 70: 1114-1118
37. Reaven GM, Hollenbeck CB, Chen YDI (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32: 52-55
38. Haffner SM, Karhapää P, Mykkänen L, Laakso M (1994) Insulin resistance, body fat distribution and sex hormones in men. Diabetes 43: 212-219
39. Groop LC, Widén E, Ferrannini E (1993) Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36: 1326-1331
40. Sbraccia P, D'Adamo M, Leonetti F et al. (1996) Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma. Diabetologia 39: 220-226
41. Faber OK, Christensen K, Kehlet H, Madsbad S, Binder C (1981) Decreased insulin removal contributes to hyperinsulinaemia in obesity. J Clin Endocrinol Metab 53: 618-621
42. Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, Prager R (1992) B-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinaemia in obese nondiabetic subjects. Metabolism 41: 1304-1312
43. Haffner SM, Bowsher RR, Mykkänen L et al. (1994) Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes 43: 1490-1493
44. Kahn SE, Leonetto DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY (1995) Proinsulin as a marker for the development of NIDDM in Japenese-American men. Diabetes 44: 173-179